Detalhe da pesquisa
1.
THE EFFECT OF ENDOPHTHALMITIS ON RECURRENCE OF MACULAR EDEMA IN EYES RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR.
Retina
; 41(7): 1470-1477, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252583
2.
OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
Retina
; 40(1): 75-79, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308561
3.
Rhegmatogenous Retinal Detachment after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor.
Ophthalmology
; 126(10): 1424-1431, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31042567
4.
Incidence and Visual Outcomes of Endophthalmitis After Intravitreal Injection of Dexamethasone Implant vs Ranibizumab.
J Vitreoretin Dis
; 6(5): 358-366, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37006897
5.
Systemic Immunosuppression and Risk of Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Ophthalmic Surg Lasers Imaging Retina
; 52(S1): S17-S22, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310237
6.
Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic Cultures.
Ophthalmol Retina
; 5(1): 16-22, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32599176
7.
Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period.
Curr Eye Res
; 46(9): 1370-1377, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33522314
8.
Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
Curr Eye Res
; 46(6): 824-830, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33522311
9.
Treatment of Eyes With Diabetic Macular Edema That Had a Suboptimal Response to Antivascular Endothelial Growth Factor Therapy: 2-mg Intravitreal Triamcinolone Acetonide vs 0.7-mg Dexamethasone Implant.
J Vitreoretin Dis
; 4(5): 372-376, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-37008292
10.
Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Semin Ophthalmol
; 35(2): 141-146, 2020 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343619
11.
Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
Can J Ophthalmol
; 55(6): 480-485, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853591
12.
Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
Am J Ophthalmol
; 207: 224-231, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31201794
13.
The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
Am J Ophthalmol
; 199: 200-208, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552891
14.
Effect of Access Site Choice on Acute Kidney Injury After Percutaneous Coronary Intervention.
Am J Cardiol
; 120(12): 2141-2145, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29100589
15.
Cardiogenic shock and access site choice.
Minerva Cardioangiol
; 65(1): 74-80, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27727197
16.
Association Between Health Insurance Status and In-Hospital Outcomes After ST-Segment Elevation Myocardial Infarction.
Am J Cardiol
; 120(7): 1049-1054, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823480